• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病的遗传和表观遗传背景。

Genetic and epigenetic background of diabetic kidney disease.

机构信息

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.

Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

出版信息

Front Endocrinol (Lausanne). 2023 May 30;14:1163001. doi: 10.3389/fendo.2023.1163001. eCollection 2023.

DOI:10.3389/fendo.2023.1163001
PMID:37324271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10262849/
Abstract

Diabetic kidney disease (DKD) is a severe diabetic complication that affects up to half of the individuals with diabetes. Elevated blood glucose levels are a key underlying cause of DKD, but DKD is a complex multifactorial disease, which takes years to develop. Family studies have shown that inherited factors also contribute to the risk of the disease. During the last decade, genome-wide association studies (GWASs) have emerged as a powerful tool to identify genetic risk factors for DKD. In recent years, the GWASs have acquired larger number of participants, leading to increased statistical power to detect more genetic risk factors. In addition, whole-exome and whole-genome sequencing studies are emerging, aiming to identify rare genetic risk factors for DKD, as well as epigenome-wide association studies, investigating DNA methylation in relation to DKD. This article aims to review the identified genetic and epigenetic risk factors for DKD.

摘要

糖尿病肾病(DKD)是一种严重的糖尿病并发症,影响多达一半的糖尿病患者。高血糖水平是 DKD 的一个主要潜在原因,但 DKD 是一种复杂的多因素疾病,需要数年时间才能发展。家族研究表明,遗传因素也会增加患病风险。在过去的十年中,全基因组关联研究(GWAS)已成为识别 DKD 遗传风险因素的有力工具。近年来,GWAS 纳入了更多的参与者,从而提高了检测更多遗传风险因素的统计能力。此外,外显子组和全基因组测序研究也在兴起,旨在识别 DKD 的罕见遗传风险因素,以及全基因组关联研究,研究与 DKD 相关的 DNA 甲基化。本文旨在综述已确定的 DKD 遗传和表观遗传风险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489a/10262849/3adea7aa8ed4/fendo-14-1163001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489a/10262849/fe939e9c7cbf/fendo-14-1163001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489a/10262849/3adea7aa8ed4/fendo-14-1163001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489a/10262849/fe939e9c7cbf/fendo-14-1163001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489a/10262849/3adea7aa8ed4/fendo-14-1163001-g002.jpg

相似文献

1
Genetic and epigenetic background of diabetic kidney disease.糖尿病肾病的遗传和表观遗传背景。
Front Endocrinol (Lausanne). 2023 May 30;14:1163001. doi: 10.3389/fendo.2023.1163001. eCollection 2023.
2
Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations.高风险人群糖尿病肾病的表观遗传风险特征。
Curr Diab Rep. 2019 Feb 7;19(3):9. doi: 10.1007/s11892-019-1129-2.
3
Genetic and epigenetic risk factors for diabetic kidney disease.糖尿病肾病的遗传和表观遗传风险因素。
Adv Chronic Kidney Dis. 2014 May;21(3):287-96. doi: 10.1053/j.ackd.2014.03.010.
4
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.糖尿病肾病和代谢记忆中的表观遗传学和表观基因组学。
Nat Rev Nephrol. 2019 Jun;15(6):327-345. doi: 10.1038/s41581-019-0135-6.
5
Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease.糖尿病肾病遗传与表观遗传变异的系统综合分析。
Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):29013-29024. doi: 10.1073/pnas.2005905117. Epub 2020 Nov 3.
6
Genetic and Epigenetic Studies in Diabetic Kidney Disease.糖尿病肾病的遗传与表观遗传学研究
Front Genet. 2019 Jun 7;10:507. doi: 10.3389/fgene.2019.00507. eCollection 2019.
7
Update: the role of epigenetics in the metabolic memory of diabetic complications.更新:表观遗传学在糖尿病并发症代谢记忆中的作用。
Am J Physiol Renal Physiol. 2024 Sep 1;327(3):F327-F339. doi: 10.1152/ajprenal.00115.2024. Epub 2024 Jul 4.
8
Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.代谢记忆对糖尿病肾病相关炎症和纤维化的影响:表观遗传学视角
Clin Epigenetics. 2021 Apr 21;13(1):87. doi: 10.1186/s13148-021-01079-5.
9
Targeting DNA methylation in diabetic kidney disease: A new perspective.靶向糖尿病肾病中的 DNA 甲基化:一个新视角。
Life Sci. 2023 Dec 15;335:122256. doi: 10.1016/j.lfs.2023.122256. Epub 2023 Nov 9.
10
DNA Methylation Changes Associated With Type 2 Diabetes and Diabetic Kidney Disease in an East Asian Population.与东亚人群 2 型糖尿病及糖尿病肾病相关的 DNA 甲基化改变。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3837-e3851. doi: 10.1210/clinem/dgab488.

引用本文的文献

1
Familial clustering of diabetic kidney disease and retinopathy in offspring of parents with type 1 diabetes: a population-based study.1型糖尿病患者后代中糖尿病肾病和视网膜病变的家族聚集性:一项基于人群的研究。
EClinicalMedicine. 2025 May 6;83:103232. doi: 10.1016/j.eclinm.2025.103232. eCollection 2025 May.
2
Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study.来自波利尼西亚与法国本土人群中经活检证实的糖尿病肾病差异:一项回顾性队列研究。
Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06471-x.
3
A Cross-Tissue Transcriptome-Wide Association Study Reveals Novel Susceptibility Genes for Diabetic Kidney Disease in the FinnGen Cohort.

本文引用的文献

1
Four missense genetic variants in are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans.在非糖尿病患者中, 中的四个错义遗传变异与更高水平的 eGFR 相关,但在糖尿病或其亚型中则不相关:一项在欧洲人群中的遗传关联研究。
Front Endocrinol (Lausanne). 2023 Feb 28;14:1081741. doi: 10.3389/fendo.2023.1081741. eCollection 2023.
2
DNA methylation is associated with glycemic control over 28 years in type 1 diabetes: findings from the Pittsburgh Epidemiology of Diabetes Complications (EDC) study.DNA 甲基化与 1 型糖尿病 28 年血糖控制相关:匹兹堡糖尿病并发症流行病学(EDC)研究结果。
BMJ Open Diabetes Res Care. 2023 Jan;11(1). doi: 10.1136/bmjdrc-2022-003068.
3
一项跨组织全转录组关联研究揭示了芬兰基因队列中糖尿病肾病的新易感基因。
Biomedicines. 2025 May 19;13(5):1231. doi: 10.3390/biomedicines13051231.
4
Emerging Biomarkers and Innovative Therapeutic Strategies in Diabetic Kidney Disease: A Pathway to Precision Medicine.糖尿病肾病中的新兴生物标志物与创新治疗策略:精准医学之路
Diagnostics (Basel). 2025 Apr 11;15(8):973. doi: 10.3390/diagnostics15080973.
5
Risk of renal complications and death in young and middle-aged Swedes with parental type 1 diabetes: a nation-wide, prospective cohort study.父母患有1型糖尿病的瑞典中青年人群发生肾脏并发症及死亡的风险:一项全国性前瞻性队列研究。
BMJ Open Diabetes Res Care. 2025 Jan 21;13(1):e004709. doi: 10.1136/bmjdrc-2024-004709.
6
Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes.血液甲基化生物标志物与1型糖尿病患者的糖尿病肾病进展相关。
medRxiv. 2024 Nov 29:2024.11.28.24318055. doi: 10.1101/2024.11.28.24318055.
7
Effect of SDF-1 and CXCR4 gene variants on the development of diabetic kidney disease.SDF-1 和 CXCR4 基因变异对糖尿病肾病发展的影响。
Int J Med Sci. 2024 Oct 28;21(14):2851-2861. doi: 10.7150/ijms.103186. eCollection 2024.
8
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease.综合多组学分析:一种增进对糖尿病肾病理解的方法。
Diabet Med. 2025 Feb;42(2):e15447. doi: 10.1111/dme.15447. Epub 2024 Oct 26.
9
Sexually dimorphic renal expression of mouse Klotho is directed by a kidney-specific distal enhancer responsive to HNF1b.小鼠 Klotho 肾脏表达的性别二态性受 HNF1b 反应的肾脏特异性远端增强子调控。
Commun Biol. 2024 Sep 14;7(1):1142. doi: 10.1038/s42003-024-06855-6.
10
Association of long noncoding RNA GAS5 gene polymorphism with progression of diabetic kidney disease.长非编码 RNA GAS5 基因多态性与糖尿病肾病进展的关系。
Int J Med Sci. 2024 Aug 13;21(11):2201-2207. doi: 10.7150/ijms.99545. eCollection 2024.
Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease.全基因组表观遗传Meta 分析鉴定与糖尿病肾病相关的 DNA 甲基化生物标志物。
Nat Commun. 2022 Dec 22;13(1):7891. doi: 10.1038/s41467-022-34963-6.
4
Whole-exome sequencing study identifies four novel gene loci associated with diabetic kidney disease.全外显子组测序研究鉴定出与糖尿病肾病相关的四个新基因座。
Hum Mol Genet. 2023 Mar 6;32(6):1048-1060. doi: 10.1093/hmg/ddac290.
5
Nidogen-1 could play a role in diabetic kidney disease development in type 2 diabetes: a genome-wide association meta-analysis.层粘连蛋白聚糖-1 可能在 2 型糖尿病中的糖尿病肾病发展中发挥作用:一项全基因组关联荟萃分析。
Hum Genomics. 2022 Oct 21;16(1):47. doi: 10.1186/s40246-022-00422-y.
6
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).慢性肾脏病中的糖尿病管理:美国糖尿病协会(ADA)和改善全球肾脏病预后组织(KDIGO)的共识报告。
Diabetes Care. 2022 Dec 1;45(12):3075-3090. doi: 10.2337/dci22-0027.
7
Genetic risk factors have a substantial impact on healthy life years.遗传风险因素对健康寿命有重大影响。
Nat Med. 2022 Sep;28(9):1893-1901. doi: 10.1038/s41591-022-01957-2. Epub 2022 Sep 12.
8
Methylation risk scores are associated with a collection of phenotypes within electronic health record systems.甲基化风险评分与电子健康记录系统中的一系列表型相关。
NPJ Genom Med. 2022 Aug 25;7(1):50. doi: 10.1038/s41525-022-00320-1.
9
Persistent blood DNA methylation changes one year after SARS-CoV-2 infection.感染 SARS-CoV-2 一年后血液 DNA 甲基化持续变化。
Clin Epigenetics. 2022 Jul 23;14(1):94. doi: 10.1186/s13148-022-01313-8.
10
Diversity in EWAS: current state, challenges, and solutions.EWAS 中的多样性:现状、挑战和解决方案。
Genome Med. 2022 Jul 6;14(1):71. doi: 10.1186/s13073-022-01065-3.